Non Opioid Treatment for Experimental Dyspnea

PHASE3CompletedINTERVENTIONAL
Enrollment

15

Participants

Timeline

Start Date

September 30, 2011

Primary Completion Date

May 31, 2012

Study Completion Date

May 31, 2012

Conditions
DyspneaPain
Interventions
DRUG

Nefopam

Subjects will be infused intravenously with nefopam (20mg/2mL) over a course of 30 minutes in a supine position. There will be a single administration of IV 20 mg nefopam and IV placebo. Each intervention will occur on a separate day.

Trial Locations (1)

75013

Pitié salpetriere Hospital, Paris

All Listed Sponsors
lead

Assistance Publique - Hôpitaux de Paris

OTHER

NCT01577407 - Non Opioid Treatment for Experimental Dyspnea | Biotech Hunter | Biotech Hunter